×

Vote ‘no’ on JD Vance for Senate

Dear Editor,

I strongly urge everyone to vote NO on JD Vance for Senate this November.

JD Vance is a venture capitalist and walking special interest, he’s anything but a public servant.

Vance’s non-profit, called Our Ohio Renewal, was founded in 2016 to fight opioid addiction but hasn’t really done that, according to non-profit experts like Doug White. Our Ohio Renewal is instead a “charade, a superficial way for him (Vance) to say he’s helping Ohio.”

Roughly half of Our Ohio Renewal’s receipts have gone to Jai Chabria, it turns out, a political strategist who’s currently advising Vance’s Senate campaign. This is immoral, and possibly illegal.

Some of the funds donated to Our Ohio Renewal may have gone to a political poll, it has been revealed, to determine if 2018 would be a good year for JD to run for Senate.

Imagine donating money to a charity, only to discover later on that your money actually went to someone’s political campaign? Our Ohio Renewal even had the gall to hire Dr. Sally Satel as a resident physician, a senior fellow from the American Enterprise Institute with ties to Purdue Pharmaceuticals, the makers of OxyContin. Dr. Satel has repeatedly suggested that addiction is the result of behavior and environment, as opposed to the ingestion of addictive pain pills.

Meanwhile Purdue Pharmaceuticals just paid out s $6 billion settlement earlier this year, to the victims of its aggressive marketing and overprescription campaigns, campaigns that resulted in the unnecessary deaths of countless individuals.

Tim Ryan, meanwhile, JD Vance’s opponent this November is a centrist Democrat, with a reputation for fighting for American workers in Congress. Ryan is an Independent, more or less, unbeholden to any party boss and/or special interest. he’s got my vote this fall.

Jeff Robertson

Yellow Springs, Ohio

Newsletter

Today's breaking news and more in your inbox

I'm interested in (please check all that apply)
Are you a paying subscriber to the newspaper? *

Starting at $4.73/week.

Subscribe Today